Follow
Kylie michelle Wagstaff
Kylie michelle Wagstaff
Verified email at monash.edu
Title
Cited by
Cited by
Year
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
L Caly, JD Druce, MG Catton, DA Jans, KM Wagstaff
Antiviral research 178, 104787, 2020
26212020
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
KM Wagstaff, H Sivakumaran, SM Heaton, D Harrich, DA Jans
Biochemical Journal 443 (3), 851-856, 2012
7982012
Targeted delivery to the nucleus
CW Pouton, KM Wagstaff, DM Roth, GW Moseley, DA Jans
Advanced drug delivery reviews 59 (8), 698-717, 2007
2972007
The Type III Effectors NleE and NleB from Enteropathogenic E. coli and OspZ from Shigella Block Nuclear Translocation of NF-κB p65
HJ Newton, JS Pearson, L Badea, M Kelly, M Lucas, G Holloway, ...
PLoS pathogens 6 (5), e1000898, 2010
2582010
The Type III Effectors NleE and NleB from Enteropathogenic E. coli and OspZ from Shigella Block Nuclear Translocation of NF-κB p65
HJ Newton, JS Pearson, L Badea, M Kelly, M Lucas, G Holloway, ...
PLoS pathogens 6 (5), e1000898, 2010
2582010
Protein transduction: cell penetrating peptides and their therapeutic applications
KM Wagstaff, DA Jans
Current medicinal chemistry 13 (12), 1371-1387, 2006
2362006
An AlphaScreen®-Based Assay for High-Throughput Screening for Specific Inhibitors of Nuclear Import
KM Wagstaff, SM Rawlinson, AC Hearps, DA Jans
Journal of biomolecular screening 16 (2), 192-200, 2011
2142011
Importins and beyond: non‐conventional nuclear transport mechanisms
KM Wagstaff, DA Jans
Traffic 10 (9), 1188-1198, 2009
2082009
Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication
L Lundberg, C Pinkham, A Baer, M Amaya, A Narayanan, KM Wagstaff, ...
Antiviral research 100 (3), 662-672, 2013
1982013
Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
M Bray, C Rayner, F Noël, D Jans, K Wagstaff
Antiviral research 178, 104805, 2020
1582020
Inhibitors of nuclear transport
DA Jans, AJ Martin, KM Wagstaff
Current opinion in cell biology 58, 50-60, 2019
1402019
Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?
L Caly, KM Wagstaff, DA Jans
Antiviral research 95 (3), 202-206, 2012
1392012
Nuclear import of the respiratory syncytial virus matrix protein is mediated by importin β1 independent of importin α
R Ghildyal, A Ho, KM Wagstaff, MM Dias, CL Barton, P Jans, P Bardin, ...
Biochemistry 44 (38), 12887-12895, 2005
1282005
A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection
JE Fraser, S Watanabe, C Wang, WKK Chan, B Maher, A Lopez-Denman, ...
The Journal of infectious diseases 210 (11), 1780-1791, 2014
982014
Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer
KM Wagstaff, DA Jans
Biochemical Journal 406 (2), 185-202, 2007
942007
Histone-mediated transduction as an efficient means for gene delivery
KM Wagstaff, DJ Glover, DJ Tremethick, DA Jans
Molecular Therapy 15 (4), 721-731, 2007
852007
Ivermectin as a broad-spectrum host-directed antiviral: the real deal?
DA Jans, KM Wagstaff
Cells 9 (9), 2100, 2020
842020
Nuclear drug delivery to target tumour cells
KM Wagstaff, DA Jans
European journal of pharmacology 625 (1-3), 174-180, 2009
732009
Intramolecular masking of nuclear localization signals: analysis of importin binding using a novel AlphaScreen-based method
KM Wagstaff, DA Jans
Analytical biochemistry 348 (1), 49-56, 2006
702006
Global enhancement of nuclear localization‐dependent nuclear transport in transformed cells
HV Kuusisto, KM Wagstaff, G Alvisi, DM Roth, DA Jans
The FASEB Journal 26 (3), 1181-1193, 2012
692012
The system can't perform the operation now. Try again later.
Articles 1–20